Welcome to our dedicated page for Ftac Hera Acqu news (Ticker: HERAW), a resource for investors and traders seeking the latest updates and insights on Ftac Hera Acqu stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ftac Hera Acqu's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ftac Hera Acqu's position in the market.
FTAC Hera Acquisition Corp. (NASDAQ:HERA) announced plans to dissolve and liquidate as it will not complete a business combination by the deadline set in its Charter. Effective March 8, 2023, the Company will redeem all Class A ordinary shares at approximately $10.17 per share. Following this date, Public Shares will be canceled and will entitle holders solely to the redemption amount. The trust account will be liquidated, and proceeds distributed to shareholders, minus expenses. Additionally, the Company expects to delist its securities from Nasdaq and terminate the registration under the Securities Exchange Act.
FTAC Hera Acquisition Corp. (NASDAQ: HERA) announced it received a notice from Nasdaq Regulation on May 28, 2021, for not filing its Quarterly Report on Form 10-Q for Q1 2021, violating Nasdaq Listing Rule 5250(c)(1). This notice does not affect the trading of its units, Class A ordinary shares, or warrants. The Company must submit a compliance plan by July 26, 2021, potentially receiving up to 180 days to regain compliance if accepted. The delay is linked to evaluating the impact of recent SEC guidance on warrants issued by SPACs.
FTAC Hera Acquisition Corp. (NASDAQ:HERAU) has announced that holders of its units will be able to separately trade Class A ordinary shares and warrants starting April 26, 2021. The units that are not separated will continue to trade under the symbol HERAU, while Class A ordinary shares and warrants are expected to trade under HERA and HERAW, respectively. Citigroup Global Markets Inc. and J.P. Morgan Securities LLC are the joint book-running managers for this offering. The registration statement for these securities was declared effective by the SEC on March 3, 2021.
FTAC Hera Acquisition Corp. (NASDAQ:HERAU) completed its initial public offering on March 8, 2021, raising $851,477,600 through the sale of 85,147,760 units at $10.00 each. The units consist of one Class A ordinary share and one-fourth of a warrant, with the latter being exercisable at $11.50. Trading began on March 4, 2021, under the symbol 'HERAU.' Citigroup and J.P. Morgan acted as joint book-running managers. The registration statement was effective as of March 3, 2021. This press release includes forward-looking statements, subject to risks outlined in the offering documents.
FTAC Hera Acquisition Corp. (NASDAQ:HERAU) has announced the pricing of its upsized initial public offering (IPO) of 80 million units at $10.00 per unit, totalling gross proceeds of $800 million. The units will start trading on the Nasdaq Capital Market on March 4, 2021, and consist of one Class A ordinary share and one-fourth of a warrant, each exercisable for one share at $11.50. The closing of the offering is expected on or around March 8, 2021. Citigroup Global Markets and J.P. Morgan Securities are the joint book-running managers, with a 45-day option for underwriters to purchase an additional 12 million units.
